Cancer Vaccines: Prevention, Treatment, and Future Frontiers
*Corresponding Author: Rakesh Nair, Department of Immunology, Amrita Institute of Medical Sciences, Amrita University, Kochi, India, Email: rakesh.nair@amrita.eduReceived Date: Aug 04, 2025 / Published Date: Aug 29, 2025
Citation: Nair R (2025) Cancer Vaccines: Prevention, Treatment, and Future Frontiers. acp 09: 295.DOI: 10.4172/2472-0429.1000295
Copyright: © 2025 Rakesh Nair This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited
Abstract
Cancer vaccines are a rapidly evolving field, focusing on preventing virus-linked malignancies like those caused by HPV and HBV. Advances include therapeutic vaccines targeting existing cancers and novel platforms like mRNA and oncolytic viruses. Optimizing vaccine efficacy involves understanding the tumor microenvironment, employing adjuvants, and integrating with immunotherapy. Personalized vaccines tailored to tumor neoantigens show promise. Key challenges include overcoming immune evasion to induce durable anti-tumor immunity for both prevention and eradication of nascent cancer cells.
